@article{article_1394794, title={The importance of second-trimester AFP and preconception TSH levels for predicting the severity of proteinuria in patients with preeclampsia}, journal={Journal of Bursa Faculty of Medicine}, volume={2}, pages={11–19}, year={2024}, DOI={10.61678/bursamed.1394794}, author={Yenigül, Nefise Nazlı and Ercan, Fedi and Başer, Emre and Yuce Bilgin, Elif and Kırım, Serpil and Bahat, Neslihan}, keywords={AFP, TSH, preeclampsia, proteinuria, pregnancy}, abstract={Objective: This study aimed to investigate the relationships between preconception thyroid stimulating hormone (TSH) and thyroxine (T4) levels, as well as second-trimester alpha-fetoprotein (AFP) levels, and the severity of proteinuria in 24-hour urine samples from patients with preeclampsia. Method: This retrospective analysis focused on preeclampsia patients categorized by proteinuria in 24-hour urine. Inclusion criteria involved patients aged 20-44 with singleton pregnancies diagnosed with preeclampsia and delivery after 20 weeks of gestation. Patients were divided into mild (0.3 to <2 g, n = 94), severe (2 to <5 g, n = 38), and massive (≥5 g, n = 11) proteinuria groups. Comparison included second-trimester AFP levels, preconception TSH, and maternal/neonatal outcomes. Results: Second-trimester AFP levels increased with proteinuria severity (mild: 47.97 ng/ml; severe: 60.52 ng/ml; massive: 65.50 ng/ml [p <0.001]). AFP emerged as a significant independent predictor of severe proteinuria (odds ratio=1.041), while TSH was not predictive (odds ratio=1.098; p=0.463). Conclusion: AFP proved to be a valuable marker for predicting proteinuria severity in 24-hour urine samples from preeclampsia patients, whereas preconception TSH was a less compelling predictor.}, number={1}, publisher={University of Health Sciences}